Company profile

DermaSensor Inc.

DermaSensor Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on January 12, 2024 and the most recent on January 12, 2024 (DermaSensor). Its most common review panel is General and Plastic Surgery (1 device).

1AI devices

2024First decision

2024Latest decision

1Specialties

Timeline

January 12, 2024 · De Novo DEN230008DermaSensor · General and Plastic Surgery · QZS